DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
GR205171
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GR205171
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAMATASVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Nonstructural protein 5A inhibitor
SAMATASVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
21P699C5FC
Molecule Type:
Small molecule
Molecular Formula:
C47H48N8O6S2
Molecular Weight:
885.08
AlogP:
9.37
PSA:
174.64
HBD:
4.0
HBA:
#RotB:
11.0
Source:
AZD2423
2
Small molecule
Investigational
Unknown
Unknown
Lung Diseases; Neuralgia; Pain; Pulmonary Disease, Chronic Obstructive
C-C chemokine receptor type 2 antagonist
AZD2423
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UPADACITINIB TARTRATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
UPADACITINIB TARTRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
7KCW9IQM02
Molecule Type:
Small molecule
Molecular Formula:
C21H33F3N6O11
Molecular Weight:
602.52
AlogP:
2.91
PSA:
78.32
HBD:
2.0
HBA:
#RotB:
3.0
Source:
JNJ-26489112
2
Small molecule
Investigational
Unknown
Unknown
Epilepsy, Reflex
Unknown
JNJ-26489112
×
Maximum Phase:
2
First Approval:
None
UNII:
G1TI012DLT
Molecule Type:
Small molecule
Molecular Formula:
C9H11ClN2O4S
Molecular Weight:
278.72
AlogP:
0.27
PSA:
90.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LIDORESTAT
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Neuropathies
Unknown
LIDORESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
9Z74BD3QPP
Molecule Type:
Small molecule
Molecular Formula:
C18H11F3N2O2S
Molecular Weight:
376.36
AlogP:
4.34
PSA:
55.12
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GPX-100
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GPX-100
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOLASTATIN 10
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DOLASTATIN 10
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BECOCALCIDIOL
2
Small molecule
Investigational
Unknown
Unknown
Psoriasis
Vitamin D receptor agonist
BECOCALCIDIOL
×
Maximum Phase:
2
First Approval:
None
UNII:
N75R59YD0F
Molecule Type:
Small molecule
Molecular Formula:
C23H36O2
Molecular Weight:
344.54
AlogP:
5.17
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
3.0
Source:
APD371
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
APD371
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACORAFLOXACIN HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Infections; Pneumonia, Bacterial
Unknown
ACORAFLOXACIN HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
1NWW5SKQ0N
Molecule Type:
Small molecule
Molecular Formula:
C21H24ClF2N3O4
Molecular Weight:
455.89
AlogP:
2.96
PSA:
97.79
HBD:
2.0
HBA:
#RotB:
5.0
Source:
GSK2982772
2
Small molecule
Investigational
Unknown
Unknown
Immune System Diseases; Inflammatory Bowel Diseases; Arthritis, Rheumatoid; Colitis, Ulcerative; Psoriasis
Receptor-interacting serine/threonine-protein kinase 1 inhibitor
GSK2982772
×
Maximum Phase:
2
First Approval:
None
UNII:
T5W3M0VO9B
Molecule Type:
Small molecule
Molecular Formula:
C20H19N5O3
Molecular Weight:
377.4
AlogP:
1.55
PSA:
100.21
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PF-04457845
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-04457845
×
Maximum Phase:
2
First Approval:
None
UNII:
H4C81M8YYW
Molecule Type:
Small molecule
Molecular Formula:
C23H20F3N5O2
Molecular Weight:
455.44
AlogP:
5.39
PSA:
80.24
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ADL-5859
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Osteoarthritis, Knee; Pain
Delta opioid receptor agonist
ADL-5859
×
Maximum Phase:
2
First Approval:
None
UNII:
FA554TW3UP
Molecule Type:
Small molecule
Molecular Formula:
C24H28N2O3
Molecular Weight:
392.5
AlogP:
3.82
PSA:
61.8
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NOX-100
2
Small molecule
Investigational
Unknown
Unknown
Hypotension
Unknown
NOX-100
×
Maximum Phase:
2
First Approval:
None
UNII:
3JWCT8LCME
Molecule Type:
Small molecule
Molecular Formula:
C8H17NO5S2
Molecular Weight:
271.36
AlogP:
-2.43
PSA:
104.39
HBD:
6.0
HBA:
#RotB:
6.0
Source:
PF-06882961
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-06882961
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRIPLATIN TETRANITRATE
2
Small molecule
Investigational
Unknown
Unknown
Lung Neoplasms; Pancreatic Neoplasms
DNA disrupting agent
TRIPLATIN TETRANITRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
HAJ1000ARC
Molecule Type:
Small molecule
Molecular Formula:
C12H50Cl2N14O12Pt3
Molecular Weight:
1238.76
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
EFATUTAZONE
2
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma; Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Liposarcoma; Thyroid Neoplasms
Unknown
EFATUTAZONE
×
Maximum Phase:
2
First Approval:
None
UNII:
M17ILL71MC
Molecule Type:
Small molecule
Molecular Formula:
C27H26N4O4S
Molecular Weight:
502.6
AlogP:
5.04
PSA:
108.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AZD2207
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Cannabinoid CB1 receptor antagonist
AZD2207
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C22H22Cl2F2N4O3+2
Molecular Weight:
499.35
AlogP:
3.67
PSA:
89.35
HBD:
4.0
HBA:
#RotB:
8.0
Source:
AZD1386
2
Small molecule
Investigational
Unknown
Unknown
Chronic Pain; Neuralgia; Pain
Vanilloid receptor antagonist
AZD1386
×
Maximum Phase:
2
First Approval:
None
UNII:
210323T9CP
Molecule Type:
Small molecule
Molecular Formula:
C19H13ClF3N3O3
Molecular Weight:
423.78
AlogP:
3.25
PSA:
78.51
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ONC-201
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ONC-201
×
Maximum Phase:
2
First Approval:
None
UNII:
9U35A31JAI
Molecule Type:
Small molecule
Molecular Formula:
C24H26N4O
Molecular Weight:
386.5
AlogP:
3.17
PSA:
39.15
HBD:
0.0
HBA:
#RotB:
4.0
Source:
OXALOACETATE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Amyotrophic Lateral Sclerosis; Glioma; Myasthenia Gravis; Breast Carcinoma In Situ; Breast Neoplasms; Parkinson Disease
Unknown
OXALOACETATE
×
Maximum Phase:
2
First Approval:
None
UNII:
2F399MM81J
Molecule Type:
Small molecule
Molecular Formula:
C4H4O5
Molecular Weight:
132.07
AlogP:
-0.89
PSA:
91.67
HBD:
2.0
HBA:
#RotB:
3.0
Source:
AZD-8848
2
Small molecule
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal
Toll-like receptor 7 agonist
AZD-8848
×
Maximum Phase:
2
First Approval:
None
UNII:
322ZMR6920
Molecule Type:
Small molecule
Molecular Formula:
C29H43N7O5
Molecular Weight:
569.71
AlogP:
2.21
PSA:
140.83
HBD:
2.0
HBA:
#RotB:
16.0
Source:
CP-461
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Renal Cell; Crohn Disease; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma; Prostatic Neoplasms, Castration-Resistant
Unknown
CP-461
×
Maximum Phase:
2
First Approval:
None
UNII:
68OJX9I7DT
Molecule Type:
Small molecule
Molecular Formula:
C25H22ClFN2O
Molecular Weight:
420.92
AlogP:
5.25
PSA:
41.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SLX-4090
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Hyperlipidemias; Hyperlipoproteinemia Type I; Hypertriglyceridemia
Microsomal triglyceride transfer protein inhibitor
SLX-4090
×
Maximum Phase:
2
First Approval:
None
UNII:
F84YQX13FV
Molecule Type:
Small molecule
Molecular Formula:
C31H25F3N2O4
Molecular Weight:
546.55
AlogP:
7.19
PSA:
67.87
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DOCUSATE
2
Small molecule
Investigational
Unknown
Unknown
Constipation; Gastroparesis
Surfactant laxative
DOCUSATE
×
Maximum Phase:
2
First Approval:
None
UNII:
M7P27195AG
Molecule Type:
Small molecule
Molecular Formula:
C20H38O7S
Molecular Weight:
422.58
AlogP:
4.15
PSA:
106.97
HBD:
1.0
HBA:
#RotB:
16.0
Source:
AG-13958
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor inhibitor
AG-13958
×
Maximum Phase:
2
First Approval:
None
UNII:
BK72RP7F7D
Molecule Type:
Small molecule
Molecular Formula:
C26H22FN7O
Molecular Weight:
467.51
AlogP:
5.31
PSA:
100.52
HBD:
3.0
HBA:
#RotB:
6.0
Source:
CCX140
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CCX140
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FORODESINE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphoid; Lymphoma; Lymphoma, T-Cell, Peripheral; Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell
Purine nucleoside phosphorylase inhibitor
FORODESINE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
6SN82Y9U73
Molecule Type:
Small molecule
Molecular Formula:
C11H15ClN4O4
Molecular Weight:
302.72
AlogP:
-2.02
PSA:
134.26
HBD:
6.0
HBA:
#RotB:
2.0
Source:
[18F]D
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
[18F]D
×
Maximum Phase:
2
First Approval:
None
UNII:
Y1H4D2VKZD
Molecule Type:
Small molecule
Molecular Formula:
C22H27FN4O2
Molecular Weight:
398.48
AlogP:
3.77
PSA:
59.73
HBD:
0.0
HBA:
#RotB:
8.0
Source:
BMS-741672
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia
C-C chemokine receptor type 2 antagonist
BMS-741672
×
Maximum Phase:
2
First Approval:
None
UNII:
3UAA36FHF1
Molecule Type:
Small molecule
Molecular Formula:
C24H33F3N6O3S
Molecular Weight:
542.63
AlogP:
2.84
PSA:
107.53
HBD:
2.0
HBA:
#RotB:
7.0
Source:
DISACCHARIDE TRIPEPTIDE GLYCEROL DIPALMITOYL
2
Small molecule
Investigational
Unknown
Unknown
Sarcoma, Ewing
Unknown
DISACCHARIDE TRIPEPTIDE GLYCEROL DIPALMITOYL
×
Maximum Phase:
2
First Approval:
None
UNII:
6PHSP9EORV
Molecule Type:
Small molecule
Molecular Formula:
C65H116N6O21
Molecular Weight:
1317.66
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MT-3995
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Nephropathies; Non-alcoholic Fatty Liver Disease
Mineralocorticoid receptor antagonist
MT-3995
×
Maximum Phase:
2
First Approval:
None
UNII:
832663U2NB
Molecule Type:
Small molecule
Molecular Formula:
C17H17FN2O4S
Molecular Weight:
364.4
AlogP:
3.03
PSA:
75.71
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CARFENTANIL
2
Small molecule
Investigational
Unknown
Unknown
Neuralgia
Unknown
CARFENTANIL
×
Maximum Phase:
2
First Approval:
None
UNII:
LA9DTA2L8F
Molecule Type:
Small molecule
Molecular Formula:
C24H30N2O3
Molecular Weight:
394.51
AlogP:
3.68
PSA:
49.85
HBD:
0.0
HBA:
#RotB:
7.0
Source:
PAMAPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
PAMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
8S2C9V11K4
Molecule Type:
Small molecule
Molecular Formula:
C19H20F2N4O4
Molecular Weight:
406.39
AlogP:
1.94
PSA:
109.5
HBD:
3.0
HBA:
#RotB:
8.0
Source:
1
2
…
132
133
134
135
136
137
138
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA